Eli Lilly’s big-selling insulin, Humalog ... Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the performance ...

One wrong move — a little too much insulin or a forgotten dose — and ... risk of hypoglycaemia and partly covering the need ...

The U.S. Food and Drug Administration has approved inhalable insulin to help patients control their blood sugar levels.

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

calculate how much insulin you’ll need. Talk with your doctor about this, but usually, 1 unit of fast-acting insulin will bring your levels down by 50 points. Calculate the number of ...

The Danish drugmaker has reported the first phase 3 results with its new basal insulin ... at mealtimes with fast-acting insulins. The results of the ONWARDS 2 trial of insulin icodec showed ...

The long-acting insulin, which will treat millions of diabetes patients, is the result of a 2022 partnership between Egyptian firm Eva Pharma and global pharmaceutical giant Eli Lilly and Company.

Dozens of school districts across multiple states have taken legal action in the U.S. District Court for the District of New ... insulin prices. The picture shows an ampule of quick-acting insulin ...

She believed she had bought an Ozempic injection but, instead, it was fast-acting insulin, which sent her into a diabetic coma. "I can't believe that I allowed my insecurities to almost kill me ...